Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors
PM534-A-001-22
Phase 2 other active
Quick answer
Phase I Study of PM534 Administered to Patients with Advanced Solid Tumors for Advanced Solid Tumors is a Phase 2 program (other) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Advanced Solid Tumors
- Phase
- Phase 2
- Modality
- other
- Status
- active